Banque de données en santé publique

Aide

Résultats de votre recherche

Votre recherche

au.\*:("JONSSON (B.)")

Document Type [dt]

A-Z Z-A Fréquence ↓ Fréquence ↑
Export CSV

Année de publication [ap]

A-Z Z-A Fréquence ↓ Fréquence ↑
Export CSV

Origine [or]

A-Z Z-A Fréquence ↓ Fréquence ↑
Export CSV

Résultats 1 à 25 sur 70

  • Page / 3

Export

Sélection :

  • et

Cost-benefit analysis of hepatitis b vaccination. = Analyse coût-bénéfice de la vaccination contre l'hépatite B.JONSSON (B.).POSTGRADUATE MEDICAL JOURNAL. 1987; 27-32ARTICLE.

Ten arguments for a societal perspective in the economic evaluation of medical innovation. = Dix arguments pour une perspective sociétale dans l'évaluation économique de l'innovation médicale.JONSSON (B.).THE EUROPEAN JOURNAL OF HEALTH ECONOMICS. 2009; 357-359ARTICLE.

Revealing the cost of Type II diabetes in Europe : The cost of diabetes Typ II in Europe : The CODE-2 study.JONSSON (B.).DIABETOLOGIA. 2002; S5-S12, issn 0012-186XARTICLE.

Cost-effectiveness : a new criterion for selecting therapy.JONSSON (B.).JOURNAL OF INTERNAL MEDICINE. 1995; 1-3, issn 0954-6820ARTICLE.

Relative effectiveness and the European pharmaceutical market. = Efficacité relative et marché pharmaceutique européen.JONSSON (B.).THE EUROPEAN JOURNAL OF HEALTH ECONOMICS. 2011; 97-102ARTICLE.

Economic evaluation alongside multinational clinical trials : Study considerations for GUSTO IIb. JONSSON (B.); WEINSTEIN (M.C.).INTERNATIONAL JOURNAL OF TECHNOLOGY ASSESSMENT IN HEALTH CARE. 1997; 49-58, issn 0266-4623ARTICLE.

The effects of cimetidine on the cost of ulcer disease in Sweden.JONSSON (B.); CARLSSON (P.).SOCIAL SCIENCE AND MEDICINE. 1991; 275-282, issn 0277-9536ARTICLE.

Health care expenditure in the nordic countries.GERDTHAM (U.G.); JONSSON (B.).HEALTH POLICY. 1994; 207-220, issn 0168-8510ARTICLE.

Health care expenditure in Sweden : an international comparison.GERDTHAM (U.G.); JONSSON (B.).HEALTH POLICY. 1991; 211-228, tabl.ARTICLE.

Health Economics of depression. = Approche économique de la dépression.JONSSON (B.); ROSENBAUM (J.).1993; 153p., tabl., fig., indexOUVRAGE.

Cost-effectiveness of clopidogrel in acute coronary syndromes in Sweden : a long-term model based on the cure trial.LINDGREN (P.); JONSSON (B.); YUSUF (S.) et al.JOURNAL OF INTERNAL MEDICINE. 2004; 562-570, issn 0954-6820ARTICLE.

Cost of breast cancer in Sweden in 2002. = Coût du cancer du sein en Suède en 2002.LIDGREN (M.); WIKING (N.); JONSSON (B.) et al.THE EUROPEAN JOURNAL OF HEALTH ECONOMICS. 2007; 5-15, 5 tabl.ARTICLE.

The role of economic evaluation in the pricing and reimbursement of medicines. DRUMMOND (M.); JONSSON (B.); RUTTEN (F.) et al.HEALTH POLICY. 1997; 199-215, graph., issn 0733-9143ARTICLE.

Estimated total costs of treating benign prostatic hyperplasia in Sweden.AHLSTRAND (C.); CARLSSON (P.); JONSSON (B.) et al.SCANDINAVIAN JOURNAL OF UROLOGY AND NEPHROLOGY. 1995; 57-63, issn 0036-5599ARTICLE.

The costs of asthma. BARNES (P.J.); JONSSON (B.); KLIM (J.B.) et al.THE EUROPEAN RESPIRATORY JOURNAL. 1996; 636-642, issn 0903-1936ARTICLE.

Joint disorders and walking disability in Sweden by the year 2000 : epidemiologic studies of a Swedish community.LARSSON (S.-E.); JONSSON (B.); PALMEFORS (L.) et al.ACTA ORTHOPAEDICA SCANDINAVICA. 1991; 6-9, issn 0300-8827ARTICLE.

The economic impact of diabetes.JONSSON (B.).DIABETES CARE. 1998; C7-C10, issn 0149-5992ARTICLE, COMMUNICATION.

Economic evaluation of medical technologies in Sweden. JONSSON (B.); SLOAN (Frank-A); GRABOWSKI (Henry-G) et al.SOCIAL SCIENCE AND MEDICINE. 1997; 597-604, issn 0277-9536ARTICLE.

Health Economics of dementia. = Analyse économique de la démence.WIMO (A.); JONSSON (B.); KARLSSON (G.) et al.1998; 576p., tabl., graph., isbn 0-471-98376-4OUVRAGE.

The costs of treating hypertension : an analysis of different cut-off points. = Les coûts du traitement de l'hypertension : une analyse des différents points de suppression.JOHANNESSON (M.); BORGQUIST (L.); JONSSON (B.) et al.HEALTH POLICY. 1991; 141-157, issn 0168-8510ARTICLE.

Outcome measurement in economic evaluations of growth factors.JONSSON (B.); KARLSSON (G.); RUTTEN (F.F.H.) et al.EUROPEAN JOURNAL OF CANCER. 1993; S19-S22ARTICLE.

Locomotion status and costs in destructive rheumatoid arthritis : a comprehensive study of 82 patients from a population of 13,000.JONSSON (B.); REHNBERG (C.); BORGQUIST (L.) et al.ACTA ORTHOPAEDICA SCANDINAVICA. 1992; 207-212, issn 0001-6470ARTICLE.

Cost-benefit analysis of non-pharmacological treatment of hypertension.JOHANNESSON (M.); ABERG (H.); AGREUS (L.) et al.JOURNAL OF INTERNAL MEDICINE. 1991; 307-312, issn 0954-6820ARTICLE.

Conversion factor instability in international comparisons of health care expenditure. = Instabilité du facteur de conversion dans la comparaison internationale des dépenses de santé.GERDTHAM (U.G.); JONSSON (B.).JOURNAL OF HEALTH ECONOMICS. 1991; 227-234, tabl.ARTICLE.

Reimbursement of pharmaceuticals : reference pricing versus health technology assessment. = Remboursement des médicaments : prix de référence versus évaluation des technologies médicales.DRUMMOND (M.); JONSSON (B.); RUTTEN (F.) et al.THE EUROPEAN JOURNAL OF HEALTH ECONOMICS. 2011; 263-271, 4 tabl.ARTICLE.

  • Page / 3